Injectable dactinomycin, an actinomycin D antibiotic, employed in combination therapies for Wilms' tumor, rhabdomyosarcoma, and choriocarcinoma. Acquired by pediatric oncology units, comprehensive cancer centers, and medical distributors for targeted antineoplastic applications.